drugset / Trial / NCT00598078
Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor
RandomizedCrossoverDouble-blindTreatment
Summary
To determine the relationship between drug plasma levels and safety, tolerability and efficacy in patients with essential tremors after dosing with Sodium oxybate
Timeline
- Start
- 2007-12
- Primary completion
- 2008-08
- Completion
- 2008-12
Outcome
Met primary endpoint
registry analysis (superiority or other test); Sodium Oxybate 3 Grams (B) vs Placebo (C); p = 0.038; ANOVA NCT00598078 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Oxybate | Unknown | — | — |